Delivery Order SPE2DB20D2104-SPE2DB25FMWLG
- Not listed
- The Defense Logistics Agency awarded a $4,586.00 delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 40 mg capsules (30-count units) on July 14, 2025, with a completion date of July 15, 2025. This firm fixed-price contract represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Carvedilol is a beta-blocker medication commonly used for heart failure and hypertension treatment,...
- The Defense Logistics Agency awarded a delivery order valued at $1,015.03 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 10 mg capsules (30-count packaging) with a firm fixed price structure. This non-set-aside, competitively awarded contract was executed on July 18, 2025, with an ultimate completion date of July 21, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Carvedilol is a beta-blocker medication used primarily for...
- The Defense Logistics Agency awarded a delivery order valued at $1,923.82 to AmerisourceBergen Drug Corp for Carvedilol ER 40 mg capsules (30-count) on July 18, 2025, with completion scheduled for July 21, 2025. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Carvedilol is a beta-blocker medication commonly used in military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $55,162.70 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 80 mg capsules (30-count units) on July 14, 2025, with an ultimate completion date of July 15, 2025. This firm fixed-price delivery order represents a non-competed award under a larger contract vehicle. The pharmaceutical product will be delivered to the vendor's facility in Conshohocken, Pennsylvania. Carvedilol is a beta-blocker medication commonly...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Carvedilol ER 80 mg capsules (30-count units) with a ceiling value of $16,575.44. This firm fixed-price delivery order, which is not set-aside and was competitively awarded, represents a direct purchase under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be supplied from the vendor's corporate office location...
- The Defense Logistics Agency awarded a $2,847.65 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Carvedilol ER 20 mg capsules (30-count units). This is a firm fixed price contract with no set-aside designation, competitively awarded under an open procurement process. The contract requires delivery by July 30, 2025, with performance taking place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. Carvedilol is a beta-blocker medication...
- The Defense Logistics Agency awarded a delivery order valued at $22,717.96 to AmerisourceBergen Drug Corp for the supply of Carvedilol ER 80 mg capsules (30-count units). This contract employs firm fixed-price terms with an ultimate completion date of August 20, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Carvedilol ER 40 mg capsules (30-count units) with a contract value of $4,019.94 and a completion date of September 22, 2025. This is a firm fixed-price, non-competitive set-aside delivery order utilizing AmerisourceBergen's existing indefinite delivery contract vehicle with DLA Troop Support Medical. The order will be fulfilled at the contractor's facility in...
- The Defense Logistics Agency awarded a delivery order valued at $1,377.29 to AmerisourceBergen Drug Corp for Carvedilol ER 80 mg capsules (30-count) on August 19, 2025, with an ultimate completion date of August 20, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Carvedilol ER 10 mg capsules (30-count packages) with a ceiling value of $9,373.09. This is a firm fixed-price delivery order with no set-aside designation, completed competitively through open procurement. The order is scheduled for completion by August 21, 2025, with performance to take place at AmerisourceBergen's corporate headquarters in Conshohocken,...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMWLGDelivery Order
The Defense Logistics Agency awarded a $9,283.93 delivery order to AmerisourceBergen Drug Corp for Carvedilol ER 40 mg capsules (30-count units) on July 25, 2025, with completion targeted for July 28, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. Carvedilol is a beta-blocker used to treat heart failure and hypertension, representing routine pharmaceutical procurement for military and federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at approximately $1 billion through December 2026. As a leading pharmaceutical distributor, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. The company's position as a primary vendor within the DLA's pharmaceutical supply chain reflects its capability to fulfill competitive federal procurement requirements across diverse therapeutic domains and transaction volumes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.3k | 7/25/25 |